NXEN Relative Valuation - Nexien Biopharma Inc

Watchlist Manager

Watchlist

Price: 0.0001 USD Market Closed

Market Cap: $7.1k

	Nexien Biopharma Inc OTC:NXEN	US
	MiniMax Group Inc HKEX:100	CN
	Brain Scientific Inc OTC:BRSF	US

Relative Value

NXEN doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of NXEN.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

NXEN Relative Value

Base Case

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Nexien Biopharma Inc OTC:NXEN	7.1k USD	0	-0	-2.3	-2.3
US		Eli Lilly and Co NYSE:LLY	853.2B USD	13.1	41.3	27.9	29.8
US		Johnson & Johnson NYSE:JNJ	566.5B USD	6	21.1	14.7	18.1
CH		Roche Holding AG SIX:ROG	243.4B CHF	4	18.9	11.2	12.6
US		Merck & Co Inc NYSE:MRK	288B USD	4.4	15.8	9.8	11.9
UK		AstraZeneca PLC LSE:AZN	214.2B GBP	5	28.5	15.8	22.3
CH		Novartis AG SIX:NOVN	225.4B CHF	5.2	21.1	13.1	16.8
IE	E	Endo International PLC LSE:0Y5F	237.1B USD	102.3	-81.1	375.3	941.3
DK		Novo Nordisk A/S CSE:NOVO B	1.1T DKK	3.4	10.4	7.7	9
US		Pfizer Inc NYSE:PFE	153.3B USD	2.4	19.7	7.6	10.1
US		Bristol-Myers Squibb Co NYSE:BMY	115.5B USD	2.4	16.4	7	8.6

				Revenue Growth	P/S to Growth
US		Nexien Biopharma Inc OTC:NXEN	Average P/S: 14.8 Not Available	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	13.1	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6	6%	1
CH		Roche Holding AG SIX:ROG	4	4%	1
US		Merck & Co Inc NYSE:MRK	4.4	5%	0.9
UK		AstraZeneca PLC LSE:AZN	5	7%	0.7
CH		Novartis AG SIX:NOVN	5.2	5%	1
IE	E	Endo International PLC LSE:0Y5F	102.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.4	2%	1.7
US		Pfizer Inc NYSE:PFE	2.4	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	2.4	-5%	N/A

				Earnings Growth	PEG
US		Nexien Biopharma Inc OTC:NXEN	Average P/E: 21.5 Negative Multiple: -0	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	41.3	32%	1.3
US		Johnson & Johnson NYSE:JNJ	21.1	7%	3
CH		Roche Holding AG SIX:ROG	18.9	14%	1.3
US		Merck & Co Inc NYSE:MRK	15.8	14%	1.1
UK		AstraZeneca PLC LSE:AZN	28.5	26%	1.1
CH		Novartis AG SIX:NOVN	21.1	14%	1.5
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -81.1	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	10.4	1%	10.4
US		Pfizer Inc NYSE:PFE	19.7	22%	0.9
US		Bristol-Myers Squibb Co NYSE:BMY	16.4	16%	1

				EBITDA Growth	EV/EBITDA to Growth
US		Nexien Biopharma Inc OTC:NXEN	Average EV/EBITDA: 49 Negative Multiple: -2.3	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	27.9	22%	1.3
US		Johnson & Johnson NYSE:JNJ	14.7	2%	7.3
CH		Roche Holding AG SIX:ROG	11.2	6%	1.9
US		Merck & Co Inc NYSE:MRK	9.8	3%	3.3
UK		AstraZeneca PLC LSE:AZN	15.8	13%	1.2
CH		Novartis AG SIX:NOVN	13.1	5%	2.6
IE	E	Endo International PLC LSE:0Y5F	375.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.7	1%	7.7
US		Pfizer Inc NYSE:PFE	7.6	-9%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	7	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
US		Nexien Biopharma Inc OTC:NXEN	Average EV/EBIT: 108 Negative Multiple: -2.3	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	29.8	22%	1.4
US		Johnson & Johnson NYSE:JNJ	18.1	6%	3
CH		Roche Holding AG SIX:ROG	12.6	6%	2.1
US		Merck & Co Inc NYSE:MRK	11.9	6%	2
UK		AstraZeneca PLC LSE:AZN	22.3	21%	1.1
CH		Novartis AG SIX:NOVN	16.8	9%	1.9
IE	E	Endo International PLC LSE:0Y5F	941.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	9	2%	4.5
US		Pfizer Inc NYSE:PFE	10.1	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	8.6	-7%	N/A

Nexien Biopharma Inc
OTC:NXEN

Relative Value

Valuation Multiples

Multiples Across Competitors

NXEN Competitors Multiples
Nexien Biopharma Inc Competitors

See Also

Company

Help

Tools

Stocks

Nexien Biopharma Inc OTC:NXEN

Relative Value

Valuation Multiples

Multiples Across Competitors

NXEN Competitors Multiples Nexien Biopharma Inc Competitors

See Also

Company

Help

Tools

Stocks

Nexien Biopharma Inc
OTC:NXEN

NXEN Competitors Multiples
Nexien Biopharma Inc Competitors